A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD)

BMC Health Services Research

Volumn 9, Issue , 2009, Pages

  Pohl, Gerhardt M ^a   Van Brunt, David L ^b   Ye, Wenyu ^c   Stoops, William W ^d   Johnston, Joseph A ^b  

^a Lilly USA   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Lilly Inter Continental Information Sciences ^*  (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; CENTRAL STIMULANT AGENT; CLONIDINE; DEXAMPEX; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; GUANFACINE; METHAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; PEMOLINE; PEMOLINE MAGNESIUM; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARMY; ARTICLE; ATTENTION DEFICIT DISORDER; BILLING AND CLAIMS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DEPRESSION; DRUG COMBINATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MENTAL DISEASE; MONOTHERAPY; PHARMACY; PRESCRIPTION; PSYCHIATRIST; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TREATMENT DURATION; UTILIZATION REVIEW; HEALTH SERVICES RESEARCH; INSURANCE; MIDDLE AGED;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 68049148421     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-9-95     Document Type: Article

References (23)

1. Adults with ADHD. An overview. PH Wender LE Wolf J Wasserstein, Ann N Y Acad Sci 2001 931 1 16
2. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. Washington DC, American Psychiatric Association Fourth 2000
3. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. S Mannuzza RG Klein A Bessler P Malloy M LaPadula, Arch Gen Psychiatry 1993 50 565 576 (Pubitemid 23203567)
4. Long-term prognosis in attention-deficit/hyperactivity disorder. S Mannuzza RG Klein, Child Adolesc Psychiatr Clin N Am 2000 9 711 726 (Pubitemid 30620551)
5. Hyperactive boys almost grown up. IV. Criminality and its relationship to psychiatric status. S Mannuzza RG Klein PH Konig TL Giampino, Arch Gen Psychiatry 1989 46 1073 1079 (Pubitemid 20016444)
6. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Biederman SV Faraone TJ Spencer E Mick MC Monuteaux M Aleardi, J Clin Psychiatry 2006 67 524 540 (Pubitemid 43764229)
7. Pharmacotherapy of adult ADHD. WW Dodson, J Clin Psychol 2005 61 589 606 (Pubitemid 40776546)
8. Does stimulant treatment lead to substance use disorders? SV Faraone T Wilens, J Clin Psychiatry 2003 64 Suppl 11 9 13 (Pubitemid 37169643)
9. Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis. SV Faraone J Biederman T Spencer D Michelson L Adler F Reimherr SJ Glatt, Behav Brain Funct 2005 1 16
10. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. AP Gibson TL Bettinger NC Patel ML Crismon, Ann Pharmacother 2006 40 1134 1142 (Pubitemid 43886972)
11. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. D Michelson L Adler T Spencer FW Reimherr SA West AJ Allen D Kelsey J Wernicke A Dietrich D Milton, Biol Psychiatry 2003 53 112 120 (Pubitemid 36126473)
12. Integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD). RO Horst RL Hendren, Essent Psychopharmacol 2005 6 250 261
13. Pharmacokinetics and clinical effectiveness of methylphenidate. HC Kimko JT Cross DR Abernethy, Clin Pharmacokinet 1999 37 457 470 (Pubitemid 30032250)
14. Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study. B Biancosino C Barbui L Marmai S Don L Grassi, Int Clin Psychopharmacol 2005 20 305 309 (Pubitemid 41475319)
15. Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia? K Karunakaran TE Tungaraza GC Harborne, J Psychopharmacol 2007 21 453 456 (Pubitemid 47077300)
16. Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. G Sanacora SF Kendell Y Levin AA Simen LR Fenton V Coric JH Krystal, Biol Psychiatry 2007 61 822 825 (Pubitemid 46330247)
17. Clinical inquiries: How should you manage a depressed patient unresponsive to an SSRI? D Triezenberg D Vachon J Helmen D Schneider, J Fam Pract 2006 55 1081 1087
18. Combination pharmacotherapy for adult ADHD. LA Adler LS Reingold MS Morrill TE Wilens, Curr Psychiatry Rep 2006 8 409 415 (Pubitemid 44515394)
19. The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder. H Ashton P Gallagher B Moore, J Psychopharmacol 2006 20 602 610 (Pubitemid 44315858)
20. Factors associated with initiation with atomoxetine versus stimulants in the treatment of adults with ADHD: retrospective analysis of administrative claims data. DL Van Brunt JA Johnston W Ye GM Pohl NN O'Hara, J Manag Care Pharm 2006 12 230 238 http://www.amcp.org/data/jmcp/Research-230-238.pdf (Pubitemid 47400612)
21. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. RC Kessler LA Adler R Barkley J Biederman CK Conners SV Faraone LL Greenhill S Jaeger K Secnik T Spencer TB Ustün AM Zaslavsky, Biol Psychiatry 2005 57 1442 1451 (Pubitemid 40798566)
22. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: Acute comparison and differential response. JH Newcorn CJ Kratochvil AJ Allen CD Casat DD Ruff RJ Moore D Michelson Atomoxetine/Methylphenidate Comparative Study Group, Am J Psychiatry 2008 165 721 730 (Pubitemid 351810541)
23. Primary care treatment of attention-deficit/hyperactivity disorder. L Culpepper, J Clin Psychiatry 2006 67 Suppl 8 51 58 (Pubitemid 44385607)